# 510(k) Summary of Safety and Effectiveness Information

This summary of $5 1 0 ( \mathbf { k } )$ safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

Submitter's Name:

Lorraine H Piestrak Dade Behring Inc. P.O. Box 6101 Newark, DE 19714-6101

Date of Preparation: June 12, 2005

# Name of Products:

Dimension Vista™M Acetaminophen (ACTM) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension VistaTM Amylase (AMY) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension VistaTM Creatine Kinase (CK) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Cholesterol (CHOL) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Gamma-glutamyl transferase (GGT) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Glucose (GLU) Flex $^ \mathrm { \textregistered }$ reagent cartridge   
Dimension Vista™M High Density Lipoprotein Cholesterol (HDLC) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Low Density Lipoprotein Cholesterol (LDLC) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Lidocaine (LIDO) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Magnesium (MG) Flex $^ \mathrm { \textregistered }$ reagent cartridge   
Dimension Vista™M Pseudocholinesterase (PCHE) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Phosphorus (PHOS) Flex® reagent cartridge   
Dimension Vista™M Procainamide (PROC) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Salicylate (SAL) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Thyroxine (T4) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Tobramycin (TOBR) Flex $^ \mathrm { \textregistered }$ reagent cartridge   
Dimension Vista™M Triglyceride (TRIG) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Uric Acid (URCA) Flex $^ \mathrm { \textregistered }$ reagent cartridge   
Dimension Vista™M Valproic Acid (VÁLP) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Vancomycin (VANC) Flex $^ \mathrm { \textregistered }$ reagent cartridge

# FDA Classification Name:

<table><tr><td colspan="2" rowspan="1">Classification Name:                                                 Common/Usual Name:</td></tr><tr><td colspan="1" rowspan="1">862.3030 Acetaminophen test system</td><td colspan="1" rowspan="1">Acetaminophen test system</td></tr><tr><td colspan="1" rowspan="1">862.1070 Amylase test system</td><td colspan="1" rowspan="1">Amylase test system</td></tr><tr><td colspan="1" rowspan="1">862.1215 Creatine kinase test system</td><td colspan="1" rowspan="1">Creatine kinase test system</td></tr><tr><td colspan="1" rowspan="1">862.1175 Cholesterol (total) test system</td><td colspan="1" rowspan="1">Cholesterol test system</td></tr><tr><td colspan="1" rowspan="1">862.1360 Gamma-glutamyl transpeptidase test system</td><td colspan="1" rowspan="1">GGT test system</td></tr><tr><td colspan="1" rowspan="1">862.1345 Glucose test system</td><td colspan="1" rowspan="1">Glucose test system</td></tr><tr><td colspan="1" rowspan="1">862.1475 Lipoprotein test system (HDL)</td><td colspan="1" rowspan="1">HDL Cholesterol test system</td></tr><tr><td colspan="1" rowspan="1">862.1475 Lipoprotein test system (LDL)</td><td colspan="1" rowspan="1">LDL Cholesterol test system</td></tr><tr><td colspan="1" rowspan="1">862.3555 Lidocaine test system</td><td colspan="1" rowspan="1">Lidocaine test system</td></tr><tr><td colspan="1" rowspan="1">862.1495 Magnesium test system</td><td colspan="1" rowspan="1">Magnesium test system</td></tr><tr><td colspan="1" rowspan="1">862.3240 Cholinesterase test system</td><td colspan="1" rowspan="1">Pseudocholinesterase test system</td></tr><tr><td colspan="1" rowspan="1">862.1580 Phosphorus (inorganic) test system</td><td colspan="1" rowspan="1">Phosphorus test system</td></tr><tr><td colspan="1" rowspan="1">862.3320 Digoxin test system ( Procainamide)</td><td colspan="1" rowspan="1">Procainamide test system</td></tr><tr><td colspan="1" rowspan="1">862.3830 Salicylate test system</td><td colspan="1" rowspan="1">Salicylate test system</td></tr><tr><td colspan="1" rowspan="1">862.1700 Total thyroxine test system</td><td colspan="1" rowspan="1">Total T4 test system</td></tr><tr><td colspan="1" rowspan="1">862.3900 Tobramycin test system</td><td colspan="1" rowspan="1">Tobramycin test system</td></tr><tr><td colspan="1" rowspan="1">862.1705 Triglyceride test system</td><td colspan="1" rowspan="1">Triglyceride test system</td></tr><tr><td colspan="1" rowspan="1">862.1775 Uric acid test system</td><td colspan="1" rowspan="1">Uric acid test system</td></tr><tr><td colspan="1" rowspan="1">862.3645 Neuroleptic drugs radioreceptor assay test system</td><td colspan="1" rowspan="1">Valproic Acid test system</td></tr><tr><td colspan="1" rowspan="1">862.3950 Vancomycin test system</td><td colspan="1" rowspan="1">Vancomycin test system</td></tr></table>

# Predicate Device:

The following table describes the predicate devices, device classification, regulation and product code associated with this pre-market notification:

<table><tr><td colspan="1" rowspan="1">New Product</td><td colspan="1" rowspan="1">Predicate</td><td colspan="1" rowspan="1">Predicate510(k) #</td><td colspan="1" rowspan="1">DeviceClass</td><td colspan="1" rowspan="1">Regulation</td><td colspan="1" rowspan="1">ProductCode</td></tr><tr><td colspan="1" rowspan="1">Dimension Vista™MACTM Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension ACTMFlex® reagentcartridge</td><td colspan="1" rowspan="1">K963244</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.3030</td><td colspan="1" rowspan="1">LDP</td></tr><tr><td colspan="1" rowspan="1">Dimension Vista™MAMY Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension® AMYFlex reagentcartridge</td><td colspan="1" rowspan="1">K942640</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.1070</td><td colspan="1" rowspan="1">JFJ</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMCK Flex® reagentcartridge</td><td colspan="1" rowspan="1">Dimension CKFlex reagentcartridge</td><td colspan="1" rowspan="1">K941584</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.1215</td><td colspan="1" rowspan="1">JHS</td></tr><tr><td colspan="1" rowspan="1">Dimension Vista™MCHOL Flexreagent cartridge</td><td colspan="1" rowspan="1">Dimension CHOLFlex® reagentcartridge</td><td colspan="1" rowspan="1">K861700</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1175</td><td colspan="1" rowspan="1">CHH</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMGGT Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension GGTFlex reagentcartridge</td><td colspan="1" rowspan="1">K861700</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1360</td><td colspan="1" rowspan="1">JQB</td></tr><tr><td colspan="1" rowspan="1">Dimension Vista™GLU Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension GLUCFlex® reagentcartridge</td><td colspan="1" rowspan="1">K031135</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.1345</td><td colspan="1" rowspan="1">CFR</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMHDLC Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension AHDLFlex reagentcartridge</td><td colspan="1" rowspan="1">K053157</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1475</td><td colspan="1" rowspan="1">LBS</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMLDLC Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension ALDLFlex® reagentcartridge</td><td colspan="1" rowspan="1">K020724</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1475</td><td colspan="1" rowspan="1">MRR</td></tr><tr><td colspan="1" rowspan="1">New Product</td><td colspan="1" rowspan="1">Predicate</td><td colspan="1" rowspan="1">Predicate510(k)</td><td colspan="1" rowspan="1">Deviceclass</td><td colspan="1" rowspan="1">Regulation</td><td colspan="1" rowspan="1">ProductCode</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMLIDO Flexreagent cartridge</td><td colspan="1" rowspan="1">Dimension® LIDOFlex reagentcartridge</td><td colspan="1" rowspan="1">K033809</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.3555</td><td colspan="1" rowspan="1">KLR</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMMG Flex® reagentcartridge</td><td colspan="1" rowspan="1">Dimension MGFlex reagentcartridge</td><td colspan="1" rowspan="1">K861700</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1495</td><td colspan="1" rowspan="1">JGJ</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMPCHE Flexreagent cartridge</td><td colspan="1" rowspan="1">Dimension PCHEFlex® reagentcartridge</td><td colspan="1" rowspan="1">K950180</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.3240</td><td colspan="1" rowspan="1">DIH</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMPHOS Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension PHOSFlex reagentcartridge</td><td colspan="1" rowspan="1">K861700</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1580</td><td colspan="1" rowspan="1">CEO</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMPROC Flexreagent cartridge</td><td colspan="1" rowspan="1">Dimension PROCFlex reagentcartridge</td><td colspan="1" rowspan="1">K032573</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.3320</td><td colspan="1" rowspan="1">LAR</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTSAL Flex® reagentcartridge</td><td colspan="1" rowspan="1">Dimension® SALFlex® reagentcartridge</td><td colspan="1" rowspan="1">K904301</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.3830</td><td colspan="1" rowspan="1">DKJ</td></tr><tr><td colspan="1" rowspan="1">Dimension Vista™MT4 Flex reagentcartridge</td><td colspan="1" rowspan="1">Dimension T4Flex® reagentcartridge</td><td colspan="1" rowspan="1">K862359</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.1700</td><td colspan="1" rowspan="1">KLI</td></tr><tr><td colspan="1" rowspan="1">Dimension Vista™MTOBR Flexreagent cartridge</td><td colspan="1" rowspan="1">Dimension® TOBRAFlex reagentcartridge</td><td colspan="1" rowspan="1">K962818</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.3900</td><td colspan="1" rowspan="1">LCR</td></tr><tr><td colspan="1" rowspan="1">Dimension Vista™MTRIG Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension TGLFlex® reagentcartridge</td><td colspan="1" rowspan="1">K010871</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1705</td><td colspan="1" rowspan="1">CDT</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMURCA Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension® URCAFlex reagentcartridge</td><td colspan="1" rowspan="1">K862359</td><td colspan="1" rowspan="1">I*</td><td colspan="1" rowspan="1">862.1775</td><td colspan="1" rowspan="1">KNK</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMVALP Flex®reagent cartridge</td><td colspan="1" rowspan="1">Dimension® VALPFlex® reagentcartridge</td><td colspan="1" rowspan="1">K982880</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.3645</td><td colspan="1" rowspan="1">LEG</td></tr><tr><td colspan="1" rowspan="1">Dimension VistaTMVANC Flexreagent cartridge</td><td colspan="1" rowspan="1">Dimension® VANCFlex® reagentcartridge</td><td colspan="1" rowspan="1">K963267</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">862.3950</td><td colspan="1" rowspan="1">LEH</td></tr></table>

\* Not exempt from premarket notification per 862.9 or per Reserved Medical Devices list

# Device Description:

Dade Behring Dimension VistaTM Flex® reagent cartridges are prepackaged in-vitro diagnostic test methods (assays) that are specifically designed to be used on the Dade Behring Dimension Vista™M Integrated system, a floor model, fully automated, microprocessor-controlled, integrated instrument system. The Dimension VistaTM system was previously cleared with seven associated test methods (K 051087). This Special 510(k) is submitted for a packaging modification to in-vitro diagnostic devices that have been cleared under the 510(k) process for use on Dimension® clinical chemistry systems. The packaging change is to allow use on the Dimension Vista™ system.

The reagents contained in the Dimension Vista™M Flex® reagent cartridges are the same as those contained in the Flex® reagent cartridges manufactured for the Dimension® clinical chemistry systems, another family of Dade Behring analyzers. The packaging modification, does not affect the intended use of the devices, nor does it alter the fundamental scientific technology of the devices.

# Intended Use:

# Acetaminophen

The ACTM method is an in vitro diagnostic test for the quantitative measurement of acetaminophen, an analgesic and antipyretic, in human serum and plasma on the Dimension VistarM System. Acetaminophen measurements may be used in the diagnosis and treatment of acetaminophen overdose.

# Amylase

The AMY method is an in vitro diagnostic test for the quantitative measurement of amylase in human serum, plasma, and urine on the Dimension Vistar System.

# Creatine Kinase

The CK method is an in vitro diagnostic test for the quantitative measurement of creatine kinase in human serum and plasma on the Dimension Vista™ System.

# Cholesterol

The CHOL method is an in vitro diagnostic test for the quantitative measurement of cholesterol in human serum and plasma on the Dimension Vista™ System.

# Gamma-glutamyl transferase

The GGT method is an in vitro diagnostic test for the quantitative measurement of gamma-glutamyl transferase in human serum and plasma on the Dimension VistaTM System.

# Glucose

The GLU method is an in vitro diagnostic test for the quantitative measurement of glucose in human serum, plasma, urine and cerebrospinal fluid on the Dimension VistaTM System.

# High-Density Lipoprotein Cholesterol

The HDLC method is an in vitro diagnostic test for the quantitative measurement of high-density lipoprotein cholesterol in human serum and plasma on the Dimension

Vista™ System. Measurements of high-density lipoprotein cholesterol are used as an aid to diagnose lipid disorders.

# Low-Density Lipoprotein Cholesterol

The LDLC method is an in vitro diagnostic test for the quantitative measurement of lowdensity lipoprotein cholesterol in human serum and plasma on the Dimension Vista System. Measurements of low-density lipoprotein cholesterol are used in the diagnosis and treatment of lipid disorders such as diabetes mellitus, atherosclerosis and various liver and renal diseases.

# Lidocaine

The LIDO method is an in vitro diagnostic test for the quantitative measurement of lidocaine in human serum and plasma on the Dimension VistaTM System. Lidocaine measurements may be used in the diagnosis and treatment of lidocaine overdose, and in therapeutic drug monitoring.

# Magnesium

The MG method is an in vitro diagnostic test for the quantitative measurement of magnesium in human serum, plasma, and urine on the Dimension Vista™M System.

# Pseuodcholinesterase

The PCHE method is an in vitro diagnostic test for the quantitative measurement of pseudocholinesterase activity in human serum and plasma on the Dimension VistaTM System. PCHE measurements may be used in the diagnosis and treatment of cholinesterase inhibition disorders.

# Phosphorus

The PHOS method is an in vitro diagnostic test for the quantitative measurement of phosphorus in human serum, plasma, and urine on the Dimension Vista™ System.

# Procainamide

The PROC method is an in vitro diagnostic test for the quantitative measurement of procainamide in human serum and plasma on the Dimension Vista™M System. Procainamide measurements may be used in the diagnosis and treatment of procainamide overdose, and in therapeutic drug monitoring.

# Salicylate

The SAL method is an in vitro diagnostic test for the quantitative measurement of salicylate in human serum on the Dimension Vista™M System. Salicylate test results may be used in the diagnosis and treatment of salicylate overdose and for monitoring salicylate levels during therapy.

# Thyroxine

The T4 method is an in vitro diagnostic test for the quantitative measurement of total thyroxine in human serum and plasma on the Dimension Vista™M System.

# Tobramycin

The TOBR method is an in vitro diagnostic test for the quantitative measurement of tobramycin, an aminoglycoside antibiotic, in human serum and plasma on the Dimension VistaTM System. Tobramycin measurements may be used in the diagnosis an treatment of tobramycin overdose and in monitoring levels of tobramycin to ensure appropriate therapy.

# Triglyceride

The TRIG method is an in vitro diagnostic test for the quantitative measurement of triglycerides in human serum and plasma on the Dimension Vista™M System.

Measurements obtained are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism or various endocrine disorders.

# Uric Acid

The URCA method is an in vitro diagnostic test for the quantitative measurement of uric acid in human serum, plasma, and urine on the Dimension Vista System.

# Valproic Acid

The VALP method is an in vitro diagnostic test for the quantitative measurement of valproic acid in human serum and plasma on the Dimension VistaTM System. Valproic acid measurements may be used in the diagnosis and treatment of valproic acid overdose andinmrng vel  alpriai suproriaethy

# Vancomycin

The VANC method is an in vitro diagnostic test for the quantitative measurement of vancomycin, a glycopeptide antibiotic, in human serum and plasma on the Dimension Vista™M System. Vancomycin measurements may be used in the diagnosis and treatment of vancomycin overdose and in monitoring levels of vancomycin to ensure appropriate therapy.

# Comparison to Predicate Device:

Both the Dimension VistaTM Flex® reagent cartridges and the predicate Dimension® Flex® reagent cartridges contain prepackaged reagents in flexible plastic, cartridges. A comparison of the important similarities and differences between the two Flex® cartridges is provided in the following table:

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Dimension Vista ™Flex® reagent cartridge</td><td rowspan=1 colspan=1>Dimension® AnalyzerFlex® reagent cartridge</td></tr><tr><td rowspan=1 colspan=1>Reagents</td><td rowspan=1 colspan=1>Prepackaged, 12-well plastic, DadeBehring Flex® reagent cartridges</td><td rowspan=1 colspan=1>Prepackaged, 6 &amp; 8 well plastic, DadeBehring Flex® reagent cartridges</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>in vitro diagnostic use</td><td rowspan=1 colspan=1>in vitro diagnostic use</td></tr><tr><td rowspan=1 colspan=1>Indications for Use</td><td rowspan=1 colspan=1>Same as Dimension® analyzer</td><td rowspan=1 colspan=1>As described in 510(k)s for eachpreviously cleared method.</td></tr><tr><td rowspan=1 colspan=1>Final concentrationof sample/reagentratio in test milieu</td><td rowspan=1 colspan=1>Same as Dimension® analyzer</td><td rowspan=1 colspan=1>As described in 510(k)s for eachpreviously cleared method</td></tr><tr><td rowspan=1 colspan=1>Tablet Sizes</td><td rowspan=1 colspan=1>7/32&quot;</td><td rowspan=1 colspan=1>7/32&quot; &amp; 9/32&quot;</td></tr><tr><td rowspan=1 colspan=1>Total tests containedin each Flex®cartridge</td><td rowspan=1 colspan=1>Approximately three times morethan contained in Dimension®Flex® reagent cartridges</td><td rowspan=1 colspan=1>As described in 510(k)s for eachpreviously cleared method.</td></tr><tr><td rowspan=1 colspan=1>Calibration</td><td rowspan=1 colspan=1>30 to 90 days(determined for each method)</td><td rowspan=1 colspan=1>30 to 90 daysAs described in 510(k)s for eachpreviously cleared method.</td></tr></table>

# Comments on Substantial Equivalence:

The Dade Behring Dimension Vista™M Flex® reagent cartridges and the Dimension® Flex® reagent cartridges are designed similarly for the same purpose. Both contain prepackagedreagents or in-iro dagnostic tests that are processedon mcoprocessorcontrolled, integrated instrument systems to analyze a variety of analytes in human specimens.

The reagents contained in the Dimension Vista™M Flex® reagent cartridges are the same as those contained in the Flex® reagent cartridges manufactured for the Dimension® clinical chemistry systems, another family of Dade Behring analyzers. The packaging modifications, do not affect the intended use of the devices, nor do they alter the fundamental scientific technology of the devices.

Comparative testing described in the protocol included in this submission demonstrates substantially equivalent performance.

# Conclusion:

The Flex® reagent cartridges, containing reagents for testing ACTM, AMY, CK, CHOL, GGT, GLU, HDLC, LDLC, LIDO, MG, PCHE, PHOS, PROC, SAL, T4, TOBR, TRIG, URCA, VALP, and VANC on the Dimension® VistaTM Integrated system are substantially equivalent in design, principle, and performance to the Dimension® system Flex® reagent cartridges. They have the same intended use and indications for use. Comparative testing also demonstrates substantially equivalent performance.

Ms. Lorraine H. Piestrak   
Regulatory Affairs & Compliance Manager Dade Behring, Inc.   
500 GBC Drive   
PO Box 6101, M/S 514   
Newark, DE 19714-6101

# JUL 10 2006

Re: k061655 Trade/Device Name: See attached list of device trade names Regulation Number: 21 CFR§862.3030 Regulation Name: Acetaminophen test system Regulatory Class: Class II Product Code: LDP, JFJ, JHS, CHH, JQB, CFR, LBS, MRR, KLR, JGJ, DIH, CEO, LAR, DKJ, KLI, LCR, CDT, KNK, LEG, LEH Dated: June 12, 2006 Received: June 13, 2006

Dear Ms. Piestrak:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, lsting o devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) pa notiicatThe ndi  ustantal equvaence  your evic ay marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/5ba7da14e235096cf090d4711b1a2089e383cce7cacbcf071987c34285b77988.jpg)

Alberto Gutierrez, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

Device/Trade Names:

Dimension Vista™ Acetaminophen (ACTM) Flex $\mathfrak { P }$ reagent cartridge   
Dimension Vista™M Amylase (AMY) Flex $\textcircled{8}$ reagent cartridge   
Dimension Vista™M Creatine Kinase (CK) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Cholesterol (CHOL) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Gamma-glutamyl transferase (GGT) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension VistaTM Glucose (GLU) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Cholesterol (CHOL) Flex $\mathfrak { P }$ reagent cartridge   
Dimension Vista™M High Density Lipoprotein Cholesterol (HDLC) Flex® reagent cartridge   
Dimension Vista™ Low- Density Lipoprotein Cholesterol $\mathrm { F l e x } ( \mathrm { L D L C } ) \textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Lidocaine (LIDO) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension VistaTM Magnesium (MG) Flex $\mathfrak { W }$ reagent cartridge   
Dimension Vista™ Pseudocholinsterase (PCHE) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Phosphorus (PHOS) Flex $\mathfrak { Q }$ reagent cartridge   
Dimension Vista™ Procainamide (PROC) Flex $\mathfrak { B }$ reagent cartridge   
Dimension Vista™M Salicylate (SAL) $\operatorname { F l e x } \langle \iff$ reagent cartridge   
Dimension VistaTM Thyroxine (T4) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Tobramycin (TOBR) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Triglyceride (TRIG) Flex $^ \mathrm { \textregistered }$ reagent cartridge   
Dimension Vista™M Uric Acid (URCA) Flex $\textsuperscript { \textregistered }$ reagent cartridge   
Dimension Vista™M Valproic Acid (VALP) Flex $^ \mathrm { \textregistered }$ reagent cartridge   
Dimension Vista™M Vancomycin (VANC) Flex $^ \mathrm { \textregistered }$ reagent cartridge

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Acetaminophen (ACTM) Flex $^ \mathrm { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Acetaminophen (ACTM) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measureacetminophen, an analgesic and antipyretic (fever reducing)dru, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of acetaminophen overdose.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

# Division Sign-Off

Office of In Vitro Diagnostic Device Evaluation and Safety

10()K061655

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Amylase (AMY) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension Vista™M Amylase (AMY) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure the activity of the enzyme amylase in serum, plasma and urine. Amylase measurements are used primarily for the diagnosis and treatment of pancreatitis (inflammation of the pancreas).

Concurrence of CDRH, Offce of In Vitro Diagnostic Devices (OIVD)

Division Sign-Off

Office of In Vitro Diagnostic Device Evaluation and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Creatine Kinase (CK) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Creatine Kinase (CK) Flex $\mathfrak { B }$ reagent cartridge is a device intended to measure the activity of the enzyme creatine kinase in serum and plasma. Measurements of creatine kinase are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive Duchenne-type muscular dystrophy.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concuence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Caf  Benin

Page3 of 20

Office of In Vitro Diagnostic Device Evaluation and Safety

K061655

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Cholesterol (CHOL) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension Vista™M Cholesterol (CHOL) Flex $\mathfrak { Q }$ reagent cartridge is a device intended to measure cholesterol in serum and plasma. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Offce of In Vitro Diagnostic Devices (OIVD)

Page of 2

Canl Beram Division Sign-Off

Office of In Vitro Diagnostic Device Evaluation and Safety

. K061655

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™M Gamma-glutamyl transferase (GGT) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Gamma-glutamyl transferase (GGT) Flex $\mathfrak { B }$ reagent cartridge is a device intended to measure gamma-glutamyl transferase in human serum and plasma. Gamma-glutamyl transferase measurements are used in the diagnosis and treatment of liver diseases such as alcoholic cirrhosis and primary and secondary liver tumors.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page of H

vision Sign-Off Caal Bna

Office of In Vitro Diagnostic Device Evaluation and Safety K061655

# Indications for Use

510(k) Number (if known):

Device Name:Dmension Vista Glucose (GLU) Flx $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension Vista™M Glucose (GLU) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure glucose in human serum, plasma, urine and cerebrospinal fluid. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal and idiopathic hypoglycemia, and pancreatic islet cell carcinoma.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Caul CBemam . ision Sign-Off

Office of In Vitro Diagnostic Device Evaluation and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™M High Density Lipoprotein Cholesterol (HDLC) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM High-Density Lipoprotein Cholesterol (HDLC) $\operatorname { F l e x } \textcircled { \mathbf { 8 } }$ reagent cartridge is intended to measure high-density lipoprotein cholesterol in serum and plasma. Measurements of high-density lipoprotein cholesterol are used in the diagnosis of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page? of 20

Canf Benen

Office of In Vitro Diagnostic Device Evaluation and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension VistaTM Low-Density Lipoprotein Cholesterol (LDLC) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension Vista™M Low-Density Lipoprotein Cholesterol (LDLC) Flex® reagent cartridge is intended to measure low-density lipoprotein cholesterol in serum and plasma. Measurements of low-density lipoprotein cholesterol are used in the diagnosis of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page of 20

Office of Iin Vitro Diagnostic Device Evaluation and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Lidocaine (LIDO) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Lidocaine (LIDO) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure lidocaine, an antiarrythmic and anticonvulsant drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of lidocaine overdose orinmonitoring levels of lidocaine to ensure appropriate therapy.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page9 of 20

Canl CAnan

Mice of In Vitro Diagnostic Device valuation and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™M Magnesium (MG) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Magnesium (MG) Flex $\textsuperscript { \textregistered }$ reagent cartridge is intended for the measurement of magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium).

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/79b63a06df5c6220361b86249deb65e134ed0d702976bf1e0d35b28eb63bb117.jpg)

Tce of In Vitro Diagnostic Device aluation and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista Pseudocholinesterase (PCHE) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension Vista™M Pseudocholinesterase (PCHE) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure pseudocholinesterase activity in human serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of cholinesterase inhibition disorders (e.g., insecticide poisoning and succinylcholine poisoning).

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page 1fof 20

Zoe ofin Vitro Dlagnostic Devig. Asation and Satety

$$
k _ { 0 } t _ { 0 } / k _ { 0 } \leq 5
$$

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™M Phosphorus (PHOS) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Phosphorus (PHOS) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure inorganic phosphorus in serum, plasma, and urine. Measurements of phosphorus (inorganic) are used in the diagnosis and treatment of various disorders, including parathyroid gland and kidney diseases, and vitamin D imbalance.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Offce of In Vitro Diagnostic Devices (OIVD)

Canol Ban

yeottoVitroDa saor. and Salew

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Procainamide (ROC) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Procainamide (PROC) Flex $^ { \textregistered }$ reagent cartridge is a device intended to measure procainamide in serum and plasma. Measurements obtained may be used in the diagnosis and treatment of procainamide overdose and in monitoring levels of procainamide to ensure appropriate therapy.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page Br0

Carof C Beneen

e of In Vitro Diagnostic Devies aation and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Salicylate (SAL) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Salicylate (SAL) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure salicylates, a class of analgesic, antipyretic and anti-inflammatory drugs that includes aspirin, in human serum. Measurements obtained by this device are used in the diagosis and treatment of salicylate overdose and in monitoring salicylate levels to ensure appropriate therapy.

Concuence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Pagd fo 200

![](images/1b2dae4e949018d6f08cf971e4f62d1dedb269099498b2266bdd36b9d5634294.jpg)

wim Diaglostic Devin Aon and Safety

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Thyroxine (T4) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Thyroxine (T4) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure total (free and protein bound) thyroxine (thyroid hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Carf CBenaon ;. Aro DiaghosticDest Cion cnd Safety K061655

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Tobramycin (TOBR) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Tobramycin (TOBR) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure tobramycin, an aminoglycoside antibiotic drug, in palsma and serum. Measurements obtained by this device are used in the diagnosis and treatment of tobramycin overdose and in monitoring levels of tobramycin to ensure appropriate therapy.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Pagelff 20

$$
K \dot { \cup } \dot { ( ) } 0 1 6 5 5
$$

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista Triglyceride (TRIG) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Triglyceride (TRIG) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure triglyceride (neutral fat) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism, or various endocrine disorders.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page of 20

CarolC Beneon Vitro DlagnosticDev on nd Sufety K061655

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Uric Acid (URCA) Flex $\mathfrak { Q }$ reagent cartridge

Indications For Use:

The Dimension VistaTM Uric Acid (URCA) Flex $\mathfrak { P }$ reagent cartridge is a device intended to measure uric acid in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and of patients receiving cytotoxic drugs.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Page 8f

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Valproic Acid (VALP) Flex $\mathfrak { Q }$ reagent cartridge

Indications For Use:

The Dimension Vista™M Valproic Acid (VALP) Flex $\textsuperscript { \textregistered }$ reagent cartridge is a device intended to measure valproic acid, an anti-convulsant drug in serum and plasma. Measurements obtained may be used in the diagnosis and treatment of valproic acid overdose and in monitoring levels of valproic acid to ensure appropriate therapy.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Pag  of

ce of In Vitro Diagnostic Devics eation and Safety K061655

# Indications for Use

510(k) Number (if known):

Device Name: Dimension Vista™ Vancomycin (VANC) Flex $\textsuperscript { \textregistered }$ reagent cartridge

Indications For Use:

The Dimension Vista™M Vancomycin (VANC) Flex $\mathfrak { P }$ reagent cartridge is a device intended to measure vancomycin, an antibiotic drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of vancomycin overdose and in monitoring the level of vancomycin to ensure appropriate therapy.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

PageNof20